Affiliation: Harvard University
- Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excludedAllen Jeremias
Division of Cardiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
Ann Intern Med 142:786-91. 2005..While troponin is a sensitive biomarker to "rule out" non-ST-segment elevation myocardial infarction, it is less useful to "rule in" this event because it may lack specificity for acute coronary syndromes...
- N-acetyl-cysteine in the prevention of vascular restenosis after percutaneous balloon angioplastyAllen Jeremias
Department of Internal Medicine, The Cleveland Clinic Foundation, Cleveland, OH, USA
Int J Cardiol 95:255-60. 2004..The aim of the study was to test the hypothesis that oral administration of N-acetyl-cysteine (NAC, a precursor of glutathione) reduces restenosis in an animal model of vascular injury...
- Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patientsRamon Kumar
Department of Medicine, Cardiology Division, Beth Israel Deaconess Medical Center, Boston, MA, USA
Am J Cardiol 100:1187-91. 2007....
- Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent proceduresAllen Jeremias
Harvard Clinical Research Institute, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
J Am Coll Cardiol 44:1210-4. 2004..This study was designed to evaluate the effect of periprocedural myocardial infarction (MI) on mortality according to success of the stent procedure...
- Drug-eluting stents and stent thrombosis: a cause for concern?Mark H Wernick
Section of Interventional Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Coron Artery Dis 17:661-5. 2006....
- The utility of troponin measurement to detect myocardial infarction: review of the current findingsMelissa A Daubert
Division of Cardiovascular Medicine, Department of Internal Medicine, Stony Brook University Medical Center, Stony Brook, NY 11794, USA
Vasc Health Risk Manag 6:691-9. 2010..This review describes the role of troponin in the evaluation of patients with suspected myocardial infarction...
- Adherence to American College of Cardiology/American Heart Association guidelines for the management of anticoagulation in patients with mechanical valves undergoing elective outpatient proceduresAjay J Kirtane
Department of Medicine Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Am J Cardiol 97:891-3. 2006..However, these data specifically suggest variability in practice for non-high-risk patients that are discordant with current ACC/AHA guidelines, with differences by treating specialty especially notable in this risk subset...
- Effects of N-acetyl-cysteine on endothelial function and inflammation in patients with type 2 diabetes mellitusAllen Jeremias
Division of Cardiology, Department of Internal Medicine, Stony Brook University Medical Center, Stony Brook, NY
Heart Int 4:e7. 2009..However, NAC therapy decreased CRP levels, suggesting that this compound may have some efficacy in reducing systemic inflammation...
- Stent thrombosis after successful sirolimus-eluting stent implantationAllen Jeremias
Section of Interventional Cardiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass, USA
Circulation 109:1930-2. 2004..5% to 1.9% of patients with bare metal stents. The incidence of ST with drug-eluting stents is less well studied, particularly among patients outside of clinical trials...
- Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunctionAllen Jeremias
Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Am Heart J 143:1040-5. 2002..Because CK-MB is frequently elevated in renal disease even in the absence of myocardial injury, the clinical significance of CK-MB elevation after PCI in patients with renal insufficiency has been questioned...
- Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiencyAllen Jeremias
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Am J Cardiol 89:1209-11. 2002